Wong Hing C's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Jun 1, 2023
- Accession no.
- 0001209191-23-033397
- Filed
- Jun 1, 2023
- Trade date
- May 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.75K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wong Hing CCIK 0001866258 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $1.55 | +$4,650 | 15,309,468 | Direct | |
| May 31, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $1.55 | +$3,100 | 15,311,468 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.